Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Floege, Jürgen
614  Ergebnisse:
Personensuche X
?
1

PHYSICAL EXERCISE IN HAEMODIALYSIS PATIENTS: which type of ..:

Halle, Martin ; Manfredini, Fabio ; Floege, Jürgen.
Clinical Kidney Journal.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Perihilar FSGS lesions originate from flat parietal epithel..:

Chia-Gil, Arnaldo ; Floege, Jürgen ; Stamellou, Eleni.
Journal of Nephrology.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

#425 Felzartamab (anti-CD38) in patients with IgA Nephropat..:

Floege, Jürgen ; Lafayette, Richard ; Barratt, Jonathan...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WI..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports.  9 (2024)  4 - p. S174 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Executive summary of the KDIGO 2024 Clinical Practice Guide..:

Floege, Jürgen ; Jayne, David R.W. ; Sanders, Jan-Stephan F....
Kidney International.  105 (2024)  3 - p. 447-449 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Management of adult patients with podocytopathies: an updat..:

Mirioglu, Safak ; Daniel-Fischer, Lisa ; Berke, Ilay...
Nephrology Dialysis Transplantation.  39 (2024)  4 - p. 569-580 , 2024
Link: https://doi.org/10.1093/..
 
?
7

Anticoagulation with osocimab in patients with kidney failu..:

Weitz, Jeffrey I. ; Tankó, László B. ; Floege, Jürgen...
Nature Medicine.  30 (2024)  2 - p. 435-442 , 2024
Link: https://doi.org/10.1038/..
 
?
8

WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, B..:

Barratt, Jonathan ; Maes, Bart ; Lin, Celia...
Kidney International Reports.  9 (2024)  4 - p. S158 , 2024
Link: https://doi.org/10.1016/..
 
?
9

#812 Phase 2b ORIGIN study open label extension with atacic..:

Lafayette, Richard ; Maes, Bart ; Israni, Rubeen...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
10

Targeted-release budesonide modifies key pathogenic biomark..:

Wimbury, David ; Muto, Masahiro ; Bhachu, Jasraj S....
Kidney International.  105 (2024)  2 - p. 381-388 , 2024
Link: https://doi.org/10.1016/..
 
?
11

KDIGO 2024 Clinical Practice Guideline for the management o..:

Rovin, Brad H. ; Ayoub, Isabelle M. ; Chan, Tak Mao...
Kidney International.  105 (2024)  1 - p. S1-S69 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial..:

Kreutz, Reinhold ; Deray, Gilbert ; Floege, Jürgen...
JACC: Advances.  3 (2024)  2 - p. 100813 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Corrigendum to "Executive summary of the KDIGO 2024 Clinica..:

Floege, Jürgen ; Jayne, David R.W. ; Sanders, Jan-Stephan F....
Kidney International.  , 2024
Link: https://doi.org/10.1016/..
 
?
14

Long-term outcomes of adults with focal segmental glomerulo..:

Stamellou, Eleni ; Nadal, Jennifer ; Hendry, Bruce...
Clinical Kidney Journal.  , 2024
Link: https://doi.org/10.1093/..
 
?
15

A phase 2b, randomized, double-blind, placebo-controlled, c..:

Lafayette, Richard ; Barbour, Sean ; Israni, Rubeen...
Kidney International.  105 (2024)  6 - p. 1306-1315 , 2024
Link: https://doi.org/10.1016/..
 
1-15